跳至主要内容
临床试验/NCT00704457
NCT00704457已完成不适用

Impact Of Sacral Neuromodulation On Urine Markers For IC

Kenneth Peters, MD1 个研究点 分布在 1 个国家目标入组 11 人开始时间: 2004年2月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
11
试验地点
1
主要终点
The purpose of this study is measure urine biomarkers levels in patients with interstitial cystitis who have elected to undergo sacral nerve stimulation as a treatment modality for their disease.

研究概览

简要总结

Urine will be collected and sent to the University of Maryland. Urines will be analyzed for urine markers.

详细描述

Urine will be collected and flash frozen in liquid nitrogen then placed in a -70 C freezer. All urine will be collected and stored until the final follow-up is complete. The urine samples will then be sent as a single batch to the Department of Infectious Disease, University of Maryland. Urines will be assayed in a blinded fashion and a written report of the levels of each of the 3 urine markers will be sent to Beaumont Hospital. Change in urine marker levels will be analyzed and correlated with change in symptom scores.

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Patients will be drawn from Dr. Peters patient base that covers Southeast Michigan.

排除标准

  • 未提供

结局指标

主要结局

The purpose of this study is measure urine biomarkers levels in patients with interstitial cystitis who have elected to undergo sacral nerve stimulation as a treatment modality for their disease.

时间窗: 1 year

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Kenneth Peters, MD

Principal Investigator

William Beaumont Hospitals

研究点 (1)

Loading locations...

相似试验